fNIRS Brain Imaging System Market Size, Growth Trends & Insights Analysis Report by Type (Desk Type and Portable Type), by Application (University, Hospital, Research Institution and Others), by Region and Competitive Landscape Forecasts, 2025 – 2033

Global fNIRS Brain Imaging System market generated revenue of USD 234.54 Million in 2024 with a CAGR of 9.15% during 2024 to 2033.

Overall, the fNIRS Brain Imaging System market is poised for continued growth in the coming years, driven by technological advancements, expanding applications, and increasing investment in research and development.

Global fNIRS Brain Imaging System Market Size (M USD) Outlook (2024-2033)

SWOT

Description

Strength

Good product performance.

fNIRS Brain Imaging System is a noninvasive and safe optical technique that uses light emitting diodes or laser diodes as NIR light sources and different NIR detectors to measure human cerebral cortex oxygenation changes in response to certain stimuli/tasks (neurovascular coupling). fNIRS measurements can be performed in a natural environment without restraint and different posture.

fNIRS technique is compatible with other electrical or magnetic monitoring systems and therapeutic devices (i.e., pacemaker, hearing aids, cochlear implants, etc.).

fNIRS Brain Imaging System advantage

The fNIRS Brain Imaging System has many advantages, such as low cost, good portability, no noise, non-invasive and not particularly sensitive to the actions of the subjects during the experiment. It can be used in various brain functional imaging studies, especially suitable for the study of brain functional imaging for young children and the elderly and special people. At the same time, more and more studies have found that fNIRS has good homogeneity with ERI, fMRI, PET and other brain functional imaging technologies.

Weakness

fNIRS Brain Imaging System is unable to provide information about brain structure for anatomical reference.

A stable contact between source/detector and skin is critical. The layering and dark color of hair attenuate NIR light. Cortical hemodynamic responses to cognitive stimuli that involve deep brain regions, such as basal ganglia and amygdale, cannot be investigated. Therefore, fNIRS measurements are restricted to outer cortex and have low spatial resolution (around 1 cm). Therefore, fNIRS measurements are restricted to outer cortex and have low spatial resolution (around 1 cm). Depth sensitivity of NIRS signal to cortical hemodynamic response depends on many factors (i.e., source-detector separation, source power, detector sensitivity, optical properties of the skin/skull layers, degree of white matter myelination). For most fNIRS systems, the typical depth sensitivity is about 1.5 cm.

The placement of multiple sources/detectors is time consuming.

Improvements of headgear and attaching are necessary. Sources/detectors cannot cover the entire head surface, making difficult the simultaneous exploration of all the possible cortical neural systems. Increasing the number of fNIRS measurement points, the weight, and the size of the headgear increase with subsequent greater movement artifacts and larger data exclusion from the data analysis.

Opportunities

The application fields are gradually extensive

In recent years, fNIRS Brain Imaging System has been rapidly applied in clinical medicine, psychiatry and other fields. Compared with other brain functional imaging techniques, fNIRS is not only used in advanced cognitive neuroscience research in laboratories, but also widely used in educational psychology, health psychology and engineering psychology. At the same time, fnirs has unique advantages in advanced cognitive neuroscience research in natural situations, developing cognitive neuroscience research and cognitive neuroscience research of special people.

The neural mechanism of brain cognition in natural situation attracts many researchers. However, due to the characteristics of imaging technology, most of the current cognitive neuroscience research is conducted under laboratory conditions, which has high requirements for experimental design and strict limits on the head movement of subjects. fNIRS is not particularly sensitive to the actions of subjects in the experimental process, so it is suitable for the research of neural mechanism of cognitive process requiring actions. In addition, this technology can be used for repeated measurement for a long time, so it is suitable for studying neural mechanism of cognitive process in natural environment.

Cost-Effectiveness

The increasing demand for non-invasive, portable and cost-effective techniques for evaluating human cortical activity is a key factor driving the demand for fNRS brain imaging system. FNRS is not disturbed by the patient’s movements, and this function is very useful in imaging the brain of the exerciser or in rehabilitation studies, in which the subject’s movements. In recent years, the demand for fNRS brain imaging system is increasingly catalyzed by the low cost and commercial availability of these devices. User-friendliness is the key attribute to improve the demand of clinicians. The fNIRS Brain Imaging System is suitable for the elderly, children and special people.

Threat

Higher requirements for product quality and brand

The fNIRS Brain Imaging System is usually purchased by official institutions such as hospitals, research institutes, and schools, which has strict requirements on product quality. Enterprises with high brand awareness and good product reputation can win customers more easily. In addition, in the field of medical devices such as fNIRS Brain Imaging System, product supervision is increasingly strict.

More and more market participants

The fNIRS Brain Imaging System is a brain function imaging technology that can meet the natural situations such as daily life and work, and is suitable for children, the elderly and special groups. at the same time, it is also considered as a technology with good prospects and can provide a new research perspective for cognitive neuroscience research. FNIRS has been rapidly applied in clinical medicine, psychiatry and other fields, attracting more and more medical device manufacturers’ attention. The number of potential entrants in the market is increasing, which increases the fierceness of market competition. The increase of market competition poses certain challenges to the quality, sales channels and after-sales guarantee of fNIRS Brain Imaging System.

The functional near-infrared spectroscopy (fNIRS) brain imaging system market in 2024 was characterized by two primary product types: Desk Type and Portable Type.

 

Desk Type fNIRS Systems

In 2024, Desk Type fNIRS systems accounted for a significant portion of the market, with a revenue of approximately $179.71 million. This represented about 76.62% of the total fNIRS market share, making it the dominant product type. The large market share can be attributed to the extensive use of these systems in academic research and clinical settings, where the need for accurate and reliable data is critical.

Portable Type fNIRS Systems

In 2024, Portable Type fNIRS systems generated a revenue of around $54.84 million, representing 23.38% of the total market share. While they had a smaller share compared to Desk Type systems, Portable Type fNIRS systems exhibited a faster growth rate. This growth can be attributed to the increasing demand for flexible and mobile brain imaging solutions in diverse research and clinical applications.

In 2024, the Desk Type fNIRS systems held the largest market share due to their extensive use in detailed research and clinical assessments. However, the Portable Type fNIRS systems demonstrated the fastest growth rate, driven by the demand for flexible and mobile brain imaging solutions in various applications. As the market continues to evolve, both product types are expected to play crucial roles in advancing brain imaging research and clinical practices.

Type

Market Size (M USD)

Market Share

Desk Type

179.71

76.62%

Portable Type

54.84

23.38%

Total

234.54

100.00%

The fNIRS brain imaging system market in 2024 was characterized by diverse applications, each with unique definitions, market sizes, and shares. The primary applications included University, Hospital, Research Institution, and Others.

University Applications

In 2024, the University application segment generated a revenue of approximately $25.31 million, accounting for 10.79% of the total fNIRS market share. While this share was relatively smaller compared to other applications, universities played a crucial role in driving innovation and research in the field of brain imaging.

Hospital Applications

In 2024, the Hospital application segment was the largest, with a revenue of around $146.79 million, representing 62.59% of the total market share. The significant market share can be attributed to the increasing use of fNIRS systems in clinical settings for early detection and monitoring of neurological conditions, improving patient outcomes.

Research Institution Applications

In 2024, the Research Institution application segment generated a revenue of approximately $45.41 million, accounting for 19.36% of the total market share. Research institutions played a vital role in advancing the understanding of brain function and driving the development of new applications for fNIRS systems.

In 2024, the Hospital application of fNIRS systems held the largest market share due to its extensive use in clinical diagnostics and patient assessments. The Research Institution segment demonstrated the fastest growth rate, driven by the need for advanced research and development in brain imaging. As the market continues to evolve, these applications, along with others, will play crucial roles in shaping the future of brain imaging and its impact on various industries.

Application

Market Size (M USD)

Market Share

University

25.31

10.79%

Hospital

146.79

62.59%

Research Institution

45.41

19.36%

Others

17.03

7.26%

Total

234.54

100.00%

The fNIRS Brain Imaging System market in 2024 exhibited significant growth across various regions, driven by increasing demand for advanced brain imaging technologies. The market was segmented into major regions, including North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

North America

North America emerged as the largest regional market in 2024, with a revenue of approximately $80.94 million, accounting for 34.51% of the global fNIRS Brain Imaging System market. This dominance can be attributed to the region’s robust healthcare infrastructure, strong research and development capabilities, and early adoption of innovative technologies.

Europe

Europe followed closely, generating a revenue of around $73.63 million in 2024, representing 31.39% of the global market share. The region’s market growth was driven by its strong emphasis on healthcare innovation and research excellence.

Asia Pacific

The Asia Pacific region experienced substantial growth in 2024, with a revenue of approximately $64.45 million, accounting for 27.48% of the global market share. This growth was primarily driven by the rapid economic development and increasing investments in healthcare and research infrastructure in the region.

South America and Middle East & Africa

South America and the Middle East & Africa had smaller market shares compared to the other regions. South America generated a revenue of $9.04 million, while the Middle East & Africa had a revenue of $6.48 million in 2024. These regions accounted for 3.85% and 2.76% of the global market share, respectively.

In 2024, North America was the largest regional market for fNIRS Brain Imaging Systems by revenue, driven by its strong healthcare infrastructure and research investments. The fastest-growing region was the Asia Pacific, where rapid economic development and increasing focus on healthcare innovation led to significant market expansion. As the global market continues to evolve, these regional dynamics will shape the future growth and adoption of fNIRS technologies worldwide.

Region

Market Size (M USD)

Market Share

North America

80.94

34.51%

Europe

73.63

31.39%

Asia Pacific

64.45

27.48%

South America

9.04

3.85%

Middle East & Africa

6.48

2.76%

Total

234.54

100.00%

Global fNIRS Brain Imaging System Revenue Market Share by Region in 2024

FUJIFILM Healthcare (Hitachi)

Company Introduction and Business Overview: FUJIFILM Healthcare, a subsidiary of Fujifilm Holdings Corporation, is a leading provider of medical imaging and diagnostic solutions. The company was established in 1934 and is headquartered in Japan. It operates globally, offering a wide range of products and services to healthcare institutions, research organizations, and educational institutions.

Products Offered: FUJIFILM Healthcare offers the ETG-4100 and ETG-4100P fNIRS systems, which are designed for both clinical and research applications. These systems provide high-resolution brain imaging and are used for various studies, including neurosurgery, psychiatry, and rehabilitation. The company’s products are known for their advanced technology and reliability, making them a popular choice among researchers and clinicians.

Revenue in 2021: In 2021, FUJIFILM Healthcare’s revenue from fNIRS Brain Imaging Systems was estimated at $111.76 million. This revenue reflects the company’s strong market position and the widespread adoption of its products in the global market.

Shimadzu Corporation

Company Introduction and Business Overview: Shimadzu Corporation, founded in 1875 and headquartered in Japan, is a global leader in precision tools and equipment. The company develops, manufactures, and sells a wide range of products, including analytical and measuring instruments, medical systems, and industrial equipment. Shimadzu’s extensive research and development efforts have enabled it to maintain a strong presence in the fNIRS market.

Products Offered: Shimadzu offers the LIGHTNIRS portable fNIRS system, which is designed for use in various research applications. The system’s portability and high performance make it suitable for studies in natural environments, such as neuromarketing, communication research, and rehabilitation research. Shimadzu’s products are known for their high scalability and measurement freedom, catering to diverse research needs.

Revenue in 2021: In 2021, Shimadzu Corporation’s revenue from fNIRS Brain Imaging Systems was estimated at $26.83 million. This revenue highlights the company’s growing influence in the market and its commitment to providing innovative solutions for brain imaging research.

Hcmedx

Company Introduction and Business Overview: Hcmedx, established in 2016 and headquartered in China, is a high-tech enterprise focused on near-infrared brain functional imaging and evaluation. The company is dedicated to providing multidimensional and quantitative brain functional imaging solutions for the diagnosis and treatment of brain diseases. Hcmedx has a strong research and development team and has developed several core patented technologies in the field of near-infrared brain functional imaging.

Products Offered: Hcmedx offers the NirSmart fNIRS system, which is a portable and lightweight device designed for various brain imaging applications. The system features high sensitivity, wireless data transmission, and long battery life, making it suitable for use in sports, educational, and clinical settings. Hcmedx’s products are known for their advanced technology and user-friendly design, catering to the needs of researchers and clinicians.

Revenue in 2021: In 2021, Hcmedx’s revenue from fNIRS Brain Imaging Systems was estimated at $5.74 million. This revenue reflects the company’s growing market presence and the increasing adoption of its innovative products in the global market.

Company

Revenue (M USD)

FUJIFILM Healthcare (Hitachi)

111.76

Shimadzu Corporation

26.83

Hcmedx

5.74

 

Share your love
en_USEnglish